November 15, 2016 11:29 AM ESTUpdated 06:40 PM
News Briefing

Low-pro­file Be­yond­Spring files for $100M IPO to back can­cer work; Ery­tech ham­mered af­ter it pulls mar­ket­ing ap­pli­ca­tion

Shehla Shakoor

Managing Director

Be­yond­Spring Phar­ma­ceu­ti­cals, a low-pro­file biotech reg­is­tered in the Cay­man Is­lands with of­fices in New York and Chi­na, has filed for a $100 mil­lion IPO. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times